Small cap News

The FDA’s designation broadens Atossa’s development pathway in DMD and could make the program eligible for a Priority Review Voucher.

Black Titan Corporation plans to develop a strategic framework to guide its future entry into digital assets.

According to Grayscale, the Trust is currently in charge of about $10.8 million in assets.

The company said the accumulation was made through Bitcoin mining and strategic purchases.

The company's stem cell drug burixafor helped nearly 90% of patients meet the Phase 2 goal.

A majority stake and eventual buyout of a company with access to Israel’s defense supply chain position Nukkleus to be a broad-based firm focused on defense AI news and the development of defense systems.

Paranovus reported a return to profitability, margin expansion, and strong contributions from its U.S. e-commerce and TikTok-focused units.

The company said it has reduced its flexible-term debt by $1.5 million, lowering total debt to $7.9 million from $9.4 million.

The plan, described as a “moonshot” structure, is designed to align leadership and early investors’ pay with long-term shareholder value.

The Tel Aviv, Israel-based company said this agreement is expected to deliver “meaningful” six-figure revenue with a strong growth potential.

DMD patients may soon gain access to a therapy that not only targets muscle decline but also tackles heart complications — the leading cause of death in this rare genetic disorder.

Here’s a look at what drove the moves and which meme stocks investors might watch for 2026.

Incannex’s Fast Track designation for IHL-42X follows strong Phase 2 data and grants the program expanded FDA access and review advantages.

The Trump administration is reportedly considering issuing an executive order on robotics in 2026, while Commerce Secretary Howard Lutnick is meeting with industry CEOs.

The Dow Jones Industrial Average was up 0.42% at the time of writing, while the S&P 500 rose 0.19%.

The RAPIDe-3 Phase 3 study is Pharvaris’ first trial for on-demand treatment of HAE attacks.

Despite big 2025 hits driving renewed interest, box office recovery remains fragile, with PwC predicting a complete rebound only by 2030 as higher ticket prices—not foot traffic—propel growth.

While Dow Jones futures were up by 0.08%, the S&P 500 futures gained 0.12%.

The drug is an IL-2 receptor-directed fusion protein designed to kill IL-2R–expressing cancer cells while depleting regulatory T cells.

Synopsys shares were up nearly 4% in Monday’s midday session after AI bellwether Nvidia announced a $2 billion investment in the company.

Omeros received $240 million upfront, with total deal value reaching up to $2.1 billion.

While Dow Jones futures were down by 0.48%, the S&P 500 futures declined 0.63%.

Imperial Petroleum announced pricing for its direct registered offering worth $60 million.

The company said that the purchase of the shares is for an exercise price of $1.71 per share and results in gross cash proceeds of about $5.68 million.

Dow Jones futures were up by 0.11% before the halt, and the S&P 500 futures rose 0.1%.

A $1 million ALS Association grant boosted excitement around PAS-004’s first ALS trial.

The company said that this investment positions it as a critical compute provider for Telegram’s Cocoon AI.

Norma Chu, the founder, chairwoman and CEO of DDC, said the company was making a long-term play.

Zage and Lu said that the Special Committee indicated that this determination was made due to uncertainty around the financing for the proposal.

The SC II units will be listed on the Nasdaq Global Market under the symbol “SCIIU.”

The company said that Judit Nagypal is also under consideration to join VisionWave’s Board of Directors.

Retail sentiment on Stocktwits around both stocks rose over the past day, despite slight pre-market share price declines.

Dow Jones futures were up by 0.17% at the time of writing, and the S&P 500 futures rose 0.32%.

Lucid-MS’s Phase 1 safety data in August supported advancement toward patient trials.

A rescue financing and loan settlement halted an impending asset seizure after Oxford’s default.

Through its controlling stake in Star 26 Capital, Nukkleus is in the process of acquiring Rimon, which has established partnerships with Rafael, Elbit Systems, and other leading defense integrators.

While Dow Jones futures were down by 0.17% at the time of writing, the S&P 500 futures fell 0.22%.

Workhorse said the Motiv merger requires shareholder approval across all proposals, even though early voting shows strong support.

The U.S.-based company said that the expanded partnership with Chongqing Liangyun Zhijing Information Technology builds on Waton’s and Panda AI’s collaboration to co-organize the Global Competition for AI Agents in Securities Trading.

RAIN token price nearly doubled, with retail sentiment on Stocktwits trending ‘bullish’ and chatter at ‘high’ levels.

Diana Shipping said it currently owns approximately 14.8% of Genco’s outstanding shares.

The companies said that under the deal terms, each share of Blue Foundry common stock will be exchanged for 0.6500 shares of Fulton common stock.

Record shareholders as of Monday will be eligible to receive the airdrop, scheduled for January.

The company said this partnership was building on the initial collaboration established in June 2024 with Sunlight Mobility.

MFI announces $500 million PIPE to support Bitcoin-backed digital asset strategy.

Many of these meme stocks have fared far worse than the Russell 2000 index.

While Dow Jones futures were up by 0.44% at the time of writing, the S&P 500 futures rose 0.17%.

Bill Waltz noted that, given the board’s decision to expand the strategic alternatives process, he has decided to stay on as CEO.

While Dow Jones futures were up by 0.61% at the time of writing, the S&P 500 futures rose 1.19%.

Mitapivat met the hemoglobin endpoint but missed the endpoints for pain crises and fatigue, prompting concerns about the mixed Phase 3 readout.